Magazine Article | May 1, 2023

Considerations For Compliance With CTIS Submissions Under The EU-CTR

Source: Life Science Leader

By Michael Halaiko and Alexandra Moylan

Effective Jan. 31, 2023, all new applications for clinical trials within the European Economic Area (EEA) must be submitted through a central web-based portal called the Clinical Trial Information System (CTIS), in accordance with the EU’s Clinical Trial Regulation (EU-CTR) under Regulation No. 536/20141. CTIS was developed and implemented to serve the dual purpose of 1) simplifying the clinical trial application process and submission of clinical trial data and results within the EEA (which consists of EU member states, plus Iceland, Norway, and Liechtenstein), and 2) furthering the EUCTR’s goal of public transparency and data availability regarding clinical trials.

access the Magazine Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Life Science Leader? Subscribe today.

Subscribe to Life Science Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Life Science Leader